Xiang Dong Tan
Chairman presso Beijing Yingrebao Investments
Profilo
Xiang Dong Tan is currently the Chairman of Beijing Yingrebao Investments, Director of Himalaya Therapeutics, and Governor of Industrial & Commercial Bank of China.
He previously held positions such as Vice Chairman & CEO of Heng Xin China Holdings Ltd., Chairman of Baoying Fund Management Co., Ltd., Chairman of China Best Group Holding Ltd., Non-Executive Chairman of Avolon Aerospace Leasing Ltd., Deputy Chairman of China Ludao Technology Co. Ltd., Independent Director of Welichem Biotech, Inc. and Mirae Asset Management Co., Ltd., Deputy General Manager of United Securities Co. Ltd.
and Nanjing Trust Investment Co., General Manager of Beijing Securities Co. Ltd., Member-Governors Board of Shenzhen Stock Exchange, and Council Member of Securities Association of China.
Dr. Tan received his doctorate degree from Xiamen University, graduate degree from Southwestern University of Finance & Economics, and undergraduate degree from Hunan University of Finance & Economics.
Posizioni attive di Xiang Dong Tan
| Società | Posizione | Inizio |
|---|---|---|
| Beijing Yingrebao Investments | Chairman | 20/10/2010 |
Industrial & Commercial Bank of China /Hubei Branch/
 Industrial & Commercial Bank of China /Hubei Branch/ Major BanksFinance Part of Industrial & Commercial Bank of China Ltd., Industrial & Commercial Bank of China /Hubei Branch/ is an international commercial bank. The private company is based in Wuchang, China. | President | 22/10/2010 |
Himalaya Therapeutics
 Himalaya Therapeutics Medical/Nursing ServicesHealth Services Himalaya Therapeutics is a Caymanian clinical-stage biotechnology company that is advancing its pipeline of novel monoclonal antibody and other protein therapeutic product candidates through clinical trials. The company is based in George Town, Cayman Islands, with operations in Taiwan and China. The company's product candidates have been developed using cab technology, which is protected by more than 500 issued and pending patents. Himalaya has two cab programs currently in phase 2 clinical testing in Taiwan\: BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC). Himalaya has a co-development and collaboration agreement for an investigational CAB CTLA-4 antibody, BA3071, with BeiGene Ltd. for its development, manufacturing, and commercialization in Greater China. The company was founded by Carolyn Anderson Short and Jay M. Short, and the CEO is Brian Zhang. | Director/Board Member | - |
Precedenti posizioni note di Xiang Dong Tan
| Società | Posizione | Fine |
|---|---|---|
| CHINA LUDAO TECHNOLOGY COMPANY LIMITED | Director/Board Member | 06/11/2020 |
| CHINA BEST GROUP HOLDING LIMITED | Chairman | 03/04/2017 |
| HENG XIN CHINA HOLDINGS LIMITED | Chief Executive Officer | 24/06/2016 |
Mirae Asset Management Co., Ltd.
 Mirae Asset Management Co., Ltd. Investment ManagersFinance Mirae Asset Management Co., Ltd. is engaged in data base activities and on-line information provision services. The company was founded on October 28, 2016 and is headquartered in Seoul, South Korea. | Director/Board Member | 01/05/2015 |
Welichem Biotech, Inc.
 Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Chairman | 23/05/2011 |
Formazione di Xiang Dong Tan
| Xiamen University | Doctorate Degree |
| Southwestern University of Finance & Economics | Graduate Degree |
| Hunan University of Finance & Economics | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CHINA BEST GROUP HOLDING LIMITED | Distribution Services |
| CHINA LUDAO TECHNOLOGY COMPANY LIMITED | Consumer Non-Durables |
| Aziende private | 14 |
|---|---|
Ingram Micro, Inc.
 Ingram Micro, Inc. Information Technology ServicesTechnology Services Ingram Micro, Inc. engages in the provision of technology solutions and logistic services. It offers cloud product services, commerce, and lifecycle services. The company was founded by Geza Czige and Lorraine Mecca in 1979 and is headquartered in Irvine, CA. | Technology Services |
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Heng Xin China Holdings Ltd.
 Heng Xin China Holdings Ltd. Telecommunications EquipmentElectronic Technology Heng Xin China Holdings Ltd. is an investment holding company. It operates through the following segments: Digital Cable Television Business, Wireless Digital Television Value-Added Services, Wireless Digital Audio Integrated Circuits, and Securities Brokerage Business. The company was founded on September 9, 2002 and is headquartered in Hong Kong. | Electronic Technology |
| United Securities Co. Ltd. | Finance |
Baoying Fund Management Co., Ltd.
 Baoying Fund Management Co., Ltd. Investment ManagersFinance Baoying Fund Management Co., Ltd. (BFM) is the asset management subsidiary of State-owned China Railway Trust Co., Ltd. in China. The firm is headquartered in Shenzhen with representative offices in Beijing and Shanghai. Founded in 2001, BFM focuses on local economic development and manages mutual funds. | Finance |
Beijing Securities Co. Ltd.
 Beijing Securities Co. Ltd. Investment Banks/BrokersFinance Beijing Securities Co. Ltd. is a private company that provides securities dealing and brokerage services. The company is based in Beijing, China. | Finance |
Shenzhen Stock Exchange
 Shenzhen Stock Exchange Investment Banks/BrokersFinance Shenzhen Stock Exchange provides real-time trading information, trade monitoring, listing compliance monitoring and general supervision services to exchange members. Its main functions include providing the venue and facilities for securities trading, formulating operational rules, receiving listing applications and arranging securities listing, organizing and supervising securities trading, supervising members; regulating listed companies, managing and disseminating market information and other functions. The company’s products cover equities, mutual funds and bonds. Shenzhen Stock Exchange was founded on December 1, 1990 and is headquartered in Shenzhen, China. | Finance |
Industrial & Commercial Bank of China /Hubei Branch/
Industrial & Commercial Bank of China /Hubei Branch/ Major BanksFinance Part of Industrial & Commercial Bank of China Ltd., Industrial & Commercial Bank of China /Hubei Branch/ is an international commercial bank. The private company is based in Wuchang, China. | Finance |
Securities Association of China
 Securities Association of China Miscellaneous Commercial ServicesCommercial Services The Securities Association of China is a non-profit organization that provides services for the securities industry. The non-profit company is based in Beijing, China. | Commercial Services |
Nanjing Trust Investment Co.
 Nanjing Trust Investment Co. Investment Trusts/Mutual FundsMiscellaneous Nanjing Trust Investment Co. provides trust and investment holding services and is ultimately controlled by the City of Nanjing. The private company is based in Nanjing, China. | Miscellaneous |
Avolon Aerospace Leasing Ltd.
 Avolon Aerospace Leasing Ltd. Aerospace & DefenseElectronic Technology Avolon Aerospace Leasing Ltd. provides aircraft leasing and lease management services to airlines and aircraft investors worldwide. The company was founded by Domhnal Slattery in May 2010 and is headquartered in Dublin, Ireland. | Electronic Technology |
| Beijing Yingrebao Investments | |
Mirae Asset Management Co., Ltd.
Mirae Asset Management Co., Ltd. Investment ManagersFinance Mirae Asset Management Co., Ltd. is engaged in data base activities and on-line information provision services. The company was founded on October 28, 2016 and is headquartered in Seoul, South Korea. | Finance |
Himalaya Therapeutics
Himalaya Therapeutics Medical/Nursing ServicesHealth Services Himalaya Therapeutics is a Caymanian clinical-stage biotechnology company that is advancing its pipeline of novel monoclonal antibody and other protein therapeutic product candidates through clinical trials. The company is based in George Town, Cayman Islands, with operations in Taiwan and China. The company's product candidates have been developed using cab technology, which is protected by more than 500 issued and pending patents. Himalaya has two cab programs currently in phase 2 clinical testing in Taiwan\: BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC). Himalaya has a co-development and collaboration agreement for an investigational CAB CTLA-4 antibody, BA3071, with BeiGene Ltd. for its development, manufacturing, and commercialization in Greater China. The company was founded by Carolyn Anderson Short and Jay M. Short, and the CEO is Brian Zhang. | Health Services |
- Borsa valori
- Insiders
- Xiang Dong Tan
